#mTNBC

Sarah has been living with relapsing MS since 2010 and believes that staying current on available treatment options positively impacts her outlook on her patient journey. #MultipleSclerosis https://t.co/et5Hl5ngr0 https://t.co/1mhcov9ito

Quoted @VukovicPetra

#ESMO20 #ASCENT: sacituzumab govitecan in previously treated mTNBC: ➡️mPFS 5.6 vs 1.7m, HR 0.41, p<0.0001 ➡️mOS 12 vs 6.7m, HR 0.48, p<0.0001 ➡️Early separation of curves ➡️ORR 35 vs 5% ➡️AE leading to discontinuation 4.7% @OncoAlert https://t.co/0Ot9KXzIvq

#ESMO20 #ASCENT: sacituzumab govitecan in previously treated mTNBC:
➡️mPFS 5.6 vs 1.7m, HR 0.41, p&lt;0.0001
➡️mOS 12 vs 6.7m, HR 0.48, p&lt;0.0001
➡️Early separation of curves
➡️ORR 35 vs 5%
➡️AE leading to discontinuation 4.7%
@OncoAlert https://t.co/0Ot9KXzIvq

Huge news for #mTNBC . Finally something that I’ll make a big impact. Can’t wait to start using Sassy-G. https://t.co/izait3XZFT

#ESMO20: Mixed results from the use of atezolizumab + nab-paclitaxel in #mTNBC: IMpassion130 shows impressive long-term benefits; negative trend in OS reported in IMpassion131. Apparent efficacy differences observed when different chemo backbones are used. https://t.co/JP0usnoEWY https://t.co/WiHUDsooUd

#ESMO20: Mixed results from the use of atezolizumab + nab-paclitaxel in #mTNBC: IMpassion130 shows impressive long-term benefits; negative trend in OS reported in IMpassion131. Apparent efficacy differences observed when different chemo backbones are used. https://t.co/JP0usnoEWY https://t.co/WiHUDsooUd

Today at the #ESMO20 Virtual Congress, we’re excited to announce full data from our Phase 3 ASCENT study in metastatic triple-negative #BreastCancer (#mTNBC). Read our press release for details: https://t.co/C5z193aYto https://t.co/rVPEOHgchq

Today at the #ESMO20 Virtual Congress, we’re excited to announce full data from our Phase 3 ASCENT study in metastatic triple-negative #BreastCancer (#mTNBC). Read our press release for details: https://t.co/C5z193aYto https://t.co/rVPEOHgchq

I’m so happy that it’s my chemo off week &amp; I felt well enough to take my sweetheart to her annual well child appointment. She’s growing like a wildflower! Thank you @VUMChealth for making us feel safe and keeping us healthy. #WearAMask #mTNBC #Stage4BreastCancer #TripleNegative https://t.co/jjH2NIfco6

I’m so happy that it’s my chemo off week & I felt well enough to take my sweetheart to her annual well child appointment. She’s growing like a wildflower! Thank you @VUMChealth for making us feel safe and keeping us healthy. #WearAMask #mTNBC #Stage4BreastCancer #TripleNegative https://t.co/jjH2NIfco6

Save the date! We will host a webcast and conference call this Saturday, September 19, at 2:00 p.m. ET to discuss the results from the #ESMO20 oral presentations in #mTNBC, metastatic #UrothelialCancer and #BrainCancer. Click here for details: https://t.co/I6CrRm168Y https://t.co/SHDvs0Gm2c

Save the date! We will host a webcast and conference call this Saturday, September 19, at 2:00 p.m. ET to discuss the results from the #ESMO20 oral presentations in #mTNBC, metastatic #UrothelialCancer and #BrainCancer. Click here for details: https://t.co/I6CrRm168Y https://t.co/SHDvs0Gm2c

Vo
10 days ago

@ArbStocktipster Rumors circulating higher bid in the works! Shorts are on fire either way! Has anyone seen $IMMU posing this in their website officially? #ESMO2020 #ESMO #mTNBC

Vo
10 days ago

Quoted @adamfeuerstein

What will it take for $GILD to break even on its $21 billion deal for $IMMU? https://t.co/njeP7iY63T via @damiangarde

Always follow AF's bulshit calls and bet against them! $IMMU $CYDY Higher bidder anyone? Rumors circulating higher bid in the works! Short at your own risk! Has anyone seen $IMMU posing this in their website officially? #ESMO2020 #ESMO #mTNBC https://t.co/uM8tB0MYI0

Vo
10 days ago

@KauriCapital @haodongvli Higher bid in the works! Shorty shorts get ready! Has anyone seen $IMMU posing this in their website officially? #ESMO2020 #ESMO #mTNBC

Vo
10 days ago

@thechartist Rumors circulating higher bid in the works! Short at your own risk! Has anyone seen $IMMU posing this in their website officially? #ESMO2020 #ESMO #mTNBC

Join us at the #ESMO20 Virtual Congress this weekend! We will share three oral presentations on our #AntibodyDrugConjugate (ADC) therapy in #mTNBC, metastatic #UrothelialCancer and #BrainCancer. Visit our virtual exhibit starting today: https://t.co/qyptZLmedR https://t.co/cinOzCOinM

Join us at the #ESMO20 Virtual Congress this weekend! We will share three oral presentations on our #AntibodyDrugConjugate (ADC) therapy in #mTNBC, metastatic #UrothelialCancer and #BrainCancer. Visit our virtual exhibit starting today: https://t.co/qyptZLmedR https://t.co/cinOzCOinM

The #GoodwinLifeSciences team advised Centerview Partners, financial advisor to Immunomedics, Inc., on the definitive agreement under which Gilead will acquire Immunomedics for $88.00 per share in cash, or approximately $21B. Read the details: https://t.co/BxKIANSPYO #ADC #mTNBC

Virtual school + 3rd day after #Trodelvy infusion AND #Neulasta means 45 minute naps with breaks in between all day long. #ThisIsMBC #Stage4NeedsMore #MTNBC #TripleNegativeBreastCancer #DyingForACure #ResearchNotRibbons #TNBCThriver

We’re virtually attending #ESMO20 on September 19-21, 2020. We’re excited to share three oral presentations on our #AntibodyDrugConjugate (ADC) therapy in #mTNBC, metastatic #UrothelialCancer and #BrainCancer. Click for more details: https://t.co/I6CrRm168Y. https://t.co/DV5CQ43z8Q

We’re virtually attending #ESMO20 on September 19-21, 2020. We’re excited to share three oral presentations on our #AntibodyDrugConjugate (ADC) therapy in #mTNBC, metastatic #UrothelialCancer and #BrainCancer. Click for more details: https://t.co/I6CrRm168Y. https://t.co/DV5CQ43z8Q

$ONCS/@OncoSec should quickly go up at least 1000% just based off their #Melanoma/#MetastaticMelanoma &amp; #TNBC/#mTNBC/#TripleNegativeBreastCancer trials📈Plus, #HeadAndNeckCancer/#SCCHN trial data should be available soon, next gen trials, #COVID19 vaccine, IP, etc, etc, etc!📈🚀 https://t.co/ncyH6P6zAm https://t.co/7YOJdNsxwv
4

$ONCS/@OncoSec should quickly go up at least 1000% just based off their #Melanoma/#MetastaticMelanoma & #TNBC/#mTNBC/#TripleNegativeBreastCancer trials📈Plus, #HeadAndNeckCancer/#SCCHN trial data should be available soon, next gen trials, #COVID19 vaccine, IP, etc, etc, etc!📈🚀 https://t.co/ncyH6P6zAm https://t.co/7YOJdNsxwv

@IamBreastCancer @eosull Let’s hope for good news in all experimental trials for #mTNBC #leronlimab https://t.co/kjOWFWyK9W

Next Page